Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
-
-
- Discovery Boost Grants (DBG)
- Arizona (AZ) Discovery Boost Grants (DBG)
- AHEAD (Advancing Health Equity and Addressing Cancer Disparities) Awards
- Mission Boost Grants (MBG)
- Research Scholar Grants
- Postdoctoral Fellowships
- Clinician Scientist Development Grant (CSDG)
- ASTRO-ACS Clinician Scientist Development Grant (CSDG)
- Institutional Research Grants
- RFA: Extramural Discovery Science Accelerator Award
- HEALED Gold Medal RFA to Support Mind-Body-Spirit Wellness in Cancer Survivors
- RFA: Cancer Health Equity Research Centers
- RFA: Real-World Data Impact Award (RWIA)
- RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
- ACS Professor Award
- Clinical Research Professor
- RFA: Metastasis in Melanoma and Other Cancers
- TheoryLab Collaborative (TLC) Grant
- Extramural Grants Department Staff Contacts
- Definition of Research Areas
- FAQs: ACS Extramural Discovery Science and Grant Application Submissions
- Extramural Priority Research Areas
-
-
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Institutional Research Grants (IRG)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- Peer Review Committee for Mission Boost Grants
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Discovery Scientific Council
- Stakeholder Participation on Grant Peer Review Committees
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Etiology, Screening, and Early Detection (ESED)
- Peer Review Committee for Cancer Prevention and Health Promotion (CPHP)
- ACS Professor Peer Review Committee
- American Cancer Society Professors
Peer Review Committee for Immunology and Blood Cell Development (IBCD)
Areas Reviewed
- Immune responses to cancer including active and passive immune therapies for cancer, adoptive transfer of autologous or allogeneic hematopoietic cells, and targeted delivery of toxic payloads
- Immune tolerance and hematopoiesis
- Molecular, structural, biochemical, and biophysical aspects of the immune system including cell types, cytokines, antigen processing, antibody molecules, and deficiencies
Peer Review Committee Members
Chair, Jose Guevara-Patino, MD, PhD, H. Lee Moffit Cancer Center and Research Institute
Co-Chair, Irina Pinchuk, PhD, Penn State University
Co-Chair, Chris Porter, MD, Emory University
Stakeholder, Alia Manetta
Stakeholder, Stacy Mendenhall
Stakeholder, Al Meyer
Stakeholder, Alexandra Solowinska
Stakeholder, Sharon Sprague
Mark Boldin, MD, PhD, Beckman Research City of Hope
Challice Bonifant, MD, PhD, Johns Hopkins University
Fan Dong, MD, PhD, University of Toledo
Jennifer Gillette, PhD, University of New Mexico
Sergei Grivennikov, PhD, Cedars-Sinai
Andras Heczey, MD, Baylor University
Michelle Krogsgaard, PhD , New York University
Rosa Lapalombella, PhD, Ohio State University
Jianmei Leavenworth, MD, PhD, University of Alabama at Birmingham
Li Ling, PhD, Beckman Research City of Hope
Max Mamonkin, PhD, Baylor University
Braden McFarland, PhD, University of Alabama at Birmingham
Bethany Mundy-Bosse, PhD, Ohio State University
Raj Muthusamy, PhD, DVM, Ohio State University
Russ Pachynski, MD, Washington University, St. Louis
Robin Parihar, MD, PhD, Baylor University
Parvarthi Ranganathan, PhD, Ohio State University
Michaela Reagan, PhD, Main Medical Center
Andrew Rezvani, MD, Stanford University
Mark Rubinstein, PhD, Ohio State University
Deepa Sampath, PhD, MD Anderson Cancer Center
Eric Sebzda, PhD, Wayne State University
Li (Lily) Wang, PhD, Cleveland Clinic
Vivian Weiss, MD, PhD, Vanderbilt University
Yibin Yang, PhD, Fox Chase Cancer Center
Jianhua Yu, PhD, Beckman Research City of Hope
Jerry Zhu, MD, PhD, Brigham and Women’s Hospital